Samuel Broder
Scientist, Person
Who is Samuel Broder?
Samuel Broder is an American oncologist and medical researcher. He was a co-developer of some of the first effective drugs for the treatment of AIDS and was Director of the National Cancer Institute from 1989 to 1995.
During the first years of the AIDS epidemic, he co-developed zidovudine, didanosine, and zalcitabine, which were the first effective drugs licensed for the treatment of AIDS. In 1989, he was appointed by President Ronald Reagan to be Director of the NCI. In this position he oversaw the development of a number of new therapies for cancer including paclitaxel. After leaving the NCI, Dr. Broder became Senior Vice President for Research and Development at the IVAX Corporation in Florida, a position he held until 1998 when he joined Celera Genomics. He is now Chief Medical Officer of Celera.
He has received a number of honors for his work including the Arthur S. Flemming Award and the Leopold Griffuel Award.
We need you!
Help us build the largest biographies collection on the web!
Citation
Use the citation below to add to a bibliography:
Style:MLAChicagoAPA
"Samuel Broder." Biographies.net. STANDS4 LLC, 2024. Web. 18 Apr. 2024. <https://www.biographies.net/people/en/samuel_broder>.
Discuss this Samuel Broder biography with the community:
Report Comment
We're doing our best to make sure our content is useful, accurate and safe.
If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Attachment
You need to be logged in to favorite.
Log In